Kala Pharmaceuticals (KALA) Earnings
|
Expand Research on KALA
| Next EPS Date | N/A | EPS Growth Rate | +45.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -14.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/8/25  |
Q225 | N/A | -$2.93 | N/A | N/A | $10.3M | N/A | N/A | N/A | ||
| 8/8/25 | Q225 | -$1.71 | $0.00 | -$1.71 | N/A | N/A | N/A |  | | Details | |
| 5/14/25 | Q125 | -$1.41 | $0.00 | -$1.41 | N/A | N/A | N/A | | | Details | |
| 8/6/24 | Q224 | -$3.16 | $0.00 | -$3.16 | N/A | N/A | N/A | | | Details | |
| 11/13/23 | Q323 | -$3.41 | -$2.15 | -$1.26 | N/A | N/A | N/A | | | Details | |
| 8/4/23 | Q223 | -$4.36 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 3/28/23 | Q422 | N/A | -$6.56 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/8/22 | Q322 | -$0.43 | $0.21 | -$0.64 | $3.07M | $41.67M | N/A | | | Details |
